Unknown

Dataset Information

0

Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons.


ABSTRACT: OBJECTIVES:Vagus nerve stimulation (VNS), most likely via enteric neurons, prevents postoperative ileus (POI) by reducing activation of alpha7 nicotinic receptor (?7nAChR) positive muscularis macrophages (mM?) and dampening surgery-induced intestinal inflammation. Here, we evaluated if 5-HT4 receptor (5-HT4R) agonist prucalopride can mimic this effect in mice and human. DESIGN:Using Ca2+ imaging, the effect of electrical field stimulation (EFS) and prucalopride was evaluated in situ on mM? activation evoked by ATP in jejunal muscularis tissue. Next, preoperative and postoperative administration of prucalopride (1-5?mg/kg) was compared with that of preoperative VNS in a model of POI in wild-type and ?7nAChR knockout mice. Finally, in a pilot study, patients undergoing a Whipple procedure were preoperatively treated with prucalopride (n=10), abdominal VNS (n=10) or sham/placebo (n=10) to evaluate the effect on intestinal inflammation and clinical recovery of POI. RESULTS:EFS reduced the ATP-induced Ca2+ response of mM?, an effect that was dampened by neurotoxins tetrodotoxin and ?-conotoxin and mimicked by prucalopride. In vivo, prucalopride administered before, but not after abdominal surgery reduced intestinal inflammation and prevented POI in wild-type, but not in ?7nAChR knockout mice. In humans, preoperative administration of prucalopride, but not of VNS, decreased Il6 and Il8 expression in the muscularis externa and improved clinical recovery. CONCLUSION:Enteric neurons dampen mM? activation, an effect mimicked by prucalopride. Preoperative, but not postoperative treatment with prucalopride prevents intestinal inflammation and shortens POI in both mice and human, indicating that preoperative administration of 5-HT4R agonists should be further evaluated as a treatment of POI. TRIAL REGISTRATION NUMBER:NCT02425774.

SUBMITTER: Stakenborg N 

PROVIDER: S-EPMC6691854 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons.

Stakenborg Nathalie N   Labeeuw Evelien E   Gomez-Pinilla Pedro J PJ   De Schepper Sebastiaan S   Aerts Raymond R   Goverse Gera G   Farro Giovanna G   Appeltans Iris I   Meroni Elisa E   Stakenborg Michelle M   Viola Maria Francesca MF   Gonzalez-Dominguez Erika E   Bosmans Goele G   Alpizar Yeranddy A YA   Wolthuis Albert A   D'Hoore Andre A   Van Beek Kim K   Verheijden Simon S   Verhaegen Marleen M   Derua Rita R   Waelkens Etienne E   Moretti Milena M   Gotti Cecilia C   Augustijns Patrick P   Talavera Karel K   Vanden Berghe Pieter P   Matteoli Gianluca G   Boeckxstaens Guy E GE  

Gut 20181124 8


<h4>Objectives</h4>Vagus nerve stimulation (VNS), most likely via enteric neurons, prevents postoperative ileus (POI) by reducing activation of alpha7 nicotinic receptor (α7nAChR) positive <i>muscularis</i> macrophages (mMφ) and dampening surgery-induced intestinal inflammation. Here, we evaluated if 5-HT4 receptor (5-HT4R) agonist prucalopride can mimic this effect in mice and human.<h4>Design</h4>Using Ca<sup>2+</sup> imaging, the effect of electrical field stimulation (EFS) and prucalopride w  ...[more]

Similar Datasets

| S-EPMC7724052 | biostudies-literature
| S-EPMC5243219 | biostudies-literature
| S-EPMC2621409 | biostudies-literature
| S-EPMC6294129 | biostudies-literature
| S-EPMC4792702 | biostudies-literature
| S-EPMC4621985 | biostudies-literature
| S-EPMC8241774 | biostudies-literature
| S-EPMC7029201 | biostudies-literature
| S-EPMC6646358 | biostudies-literature
| S-EPMC4937649 | biostudies-literature